Valuation: Farmacias Benavides, S.A.B. de C.V.

Market Cap 10.22B 553M 497M 464M 420M 789M 52.59B 794M 5.57B 2.17B 27.3B 2.07B 2.03B 87.79B P/E 2024
68.9x
P/E 2025 47.4x
Enterprise Value 11.96B 646M 581M 542M 492M 923M 61.52B 929M 6.51B 2.54B 31.93B 2.43B 2.37B 103B EV / Sales 2024
0.69x
EV / Sales 2025 0.64x
Free-Float
16.07%
Yield 2024 *
-
Yield 2025 -
10-07 Canada's Weston family to buy UK's Boots in $8.9 billion deal RE
07-31 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-26 Mexico's Farmacias Benavides starts process to delist from official securities registry RE
04-30 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-26 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
25-10-28 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-07-28 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-04-29 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-02-26 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
24-08-15 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-13 Farmacias Benavides, S.A.B. de C.V. Auditor Raises 'Going Concern' Doubt CI
24-04-25 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-02-26 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Manager TitleAgeSince
Chief Executive Officer - 2024-12-01
Director of Finance/CFO - 2026-03-16
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 2020-12-31
Chairman - 2023-05-01
Director/Board Member - 2023-05-01
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 557M
+13.68%-1.09%+13.54%-23.57% 7.23B
+0.16%+1.87%-15.01%-3.81% 6.13B
-0.52%-0.94%-13.61%+1.28% 6.06B
+0.71%+9.09%+3.71%-8.99% 4.57B
+0.26%+4.34%+14.26%-21.76% 3.22B
-0.34%-1.28%-26.77%-9.80% 3.13B
-3.19%-5.04%-28.37%-38.76% 3.1B
+9.46%+12.52%-35.22%-7.86% 3.33B
+0.75%-0.90%-27.17%+25.68% 2.84B
Average +2.10%+3.40%-12.74%-9.73% 4.4B
Weighted average by Cap. +3.08%+3.94%-9.58%-10.13%

Financials

2024 2025
Net sales 17.65B 954M 858M 801M 726M 1.36B 90.8B 1.37B 9.61B 3.75B 47.13B 3.58B 3.5B 152B 19.46B 1.05B 946M 883M 800M 1.5B 100B 1.51B 10.59B 4.14B 51.97B 3.95B 3.86B 167B
Net income 131M 7.06M 6.35M 5.92M 5.37M 10.08M 672M 10.14M 71.07M 27.75M 349M 26.5M 25.92M 1.12B 224M 12.12M 10.89M 10.17M 9.21M 17.3M 1.15B 17.41M 122M 47.64M 598M 45.49M 44.51M 1.92B
Net Debt 3.26B 176M 158M 148M 134M 252M 16.77B 253M 1.77B 693M 8.7B 662M 647M 28B 1.73B 93.79M 84.33M 78.69M 71.32M 134M 8.93B 135M 944M 369M 4.63B 352M 344M 14.9B
Logo Farmacias Benavides, S.A.B. de C.V.
Farmacias Benavides SAB de CV is a Mexico-based company primarily engaged in the pharmaceutical and chemical industry. The Company operates a network of over 700 drug stores located nationwide under the Farmacias Benavides name. Through its network of drug stores, it sells a variety prescription and over the counter (OTC) medicines, cosmetics, personal and baby care products and toiletries, as well as it also provides such related services as laboratory samples, home delivery, prescription laboratory, online pharmacy and photo processing services. As of December 31, 2011, the Company owned such subsidiaries as Servicios Operacionales Benavides SA de CV, Benavides de Reynosa SA de CV and Servicios Logisticos Benavides SA de CV, and Fasa Investment Limitada which was its majority shareholder with 85.25% of its interest.
Employees
-